TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Neuronetics ( (STIM) ) just unveiled an announcement.
On November 4, 2025, Neuronetics announced that CEO Keith J. Sullivan will retire on June 30, 2026, and the company has started searching for his successor. Sullivan will remain as a consultant post-retirement to ensure a smooth transition. The announcement coincided with the release of Neuronetics’ third-quarter 2025 financial results, showing a 101% increase in total revenue compared to the same period in 2024, driven by the acquisition of Greenbrook TMS. The company reported significant growth in U.S. clinic revenue and continued improvements in cash management, positioning it well for future growth and value delivery to patients and shareholders.
The most recent analyst rating on (STIM) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Neuronetics stock, see the STIM Stock Forecast page.
Spark’s Take on STIM Stock
According to Spark, TipRanks’ AI Analyst, STIM is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance and poor valuation metrics. While there is some positive momentum in technical indicators, the persistent financial challenges and negative valuation metrics weigh heavily on the score.
To see Spark’s full report on STIM stock, click here.
More about Neuronetics
Neuronetics, Inc. is a vertically integrated, commercial stage medical technology and healthcare company focused on providing leading neurohealth therapies. The company is known for its NeuroStar Advanced Therapy System, which is used to treat major depressive disorder and other neurohealth conditions. Neuronetics operates primarily in the United States and has a strategic vision of transforming patient lives with its advanced therapies.
Average Trading Volume: 1,366,449
Technical Sentiment Signal: Sell
Current Market Cap: $183.2M
Find detailed analytics on STIM stock on TipRanks’ Stock Analysis page.